Cargando…

Primary hepatic carcinosarcoma with multimodal treatment

Hepatic carcinosarcoma (HCS) generally presents in advanced stages, demonstrates aggressive behavior, and has a poor prognosis. Other than curative primary resection, no effective treatment options exist. We present a case of resected HCS with four repeat resections for solitary lymph node recurrenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurita, Daisuke, Mokuno, Yasuji, Matsubara, Hideo, Kaneko, Hirokazu, Shamoto, Mikihiro, Satou, Akira, Iyomasa, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125652/
https://www.ncbi.nlm.nih.gov/pubmed/30214092
http://dx.doi.org/10.18999/nagjms.80.3.423
_version_ 1783353199971794944
author Kurita, Daisuke
Mokuno, Yasuji
Matsubara, Hideo
Kaneko, Hirokazu
Shamoto, Mikihiro
Satou, Akira
Iyomasa, Shinsuke
author_facet Kurita, Daisuke
Mokuno, Yasuji
Matsubara, Hideo
Kaneko, Hirokazu
Shamoto, Mikihiro
Satou, Akira
Iyomasa, Shinsuke
author_sort Kurita, Daisuke
collection PubMed
description Hepatic carcinosarcoma (HCS) generally presents in advanced stages, demonstrates aggressive behavior, and has a poor prognosis. Other than curative primary resection, no effective treatment options exist. We present a case of resected HCS with four repeat resections for solitary lymph node recurrence followed by chemoradiotherapy with doxorubicin and ifosfamide. A 67-year-old Japanese man was admitted to our hospital for evaluation of an asymptomatic hepatic tumor. The patient underwent right hepatectomy with a presumptive preoperative diagnosis of atypical hepatocellular carcinoma. Based on histopathological and immunohistochemical findings, the tumor was diagnosed as HCS containing osteosarcoma and chondrosarcoma components. After the initial surgery, the patient underwent four additional resections for solitary lymph node HCS recurrence, and then underwent chemoradiotherapy with doxorubicin and ifosfamide for an unresectable lymph node recurrence. Chemotherapy was stopped after two cycles because of severe adverse events, although chemoradiotherapy markedly reduced the size of the lymph node recurrence and provided a progression-free survival of 12 months. Thirty-seven months after the initial surgery, the patient died of cardiac invasion of multiple mediastinal lymph node metastases. The clinical course outlined in this case report suggests that chemoradiotherapy with doxorubicin and ifosfamide for metastatic HCS may prolong survival in patients with unresectable lesions.
format Online
Article
Text
id pubmed-6125652
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nagoya University
record_format MEDLINE/PubMed
spelling pubmed-61256522018-09-13 Primary hepatic carcinosarcoma with multimodal treatment Kurita, Daisuke Mokuno, Yasuji Matsubara, Hideo Kaneko, Hirokazu Shamoto, Mikihiro Satou, Akira Iyomasa, Shinsuke Nagoya J Med Sci Case Report Hepatic carcinosarcoma (HCS) generally presents in advanced stages, demonstrates aggressive behavior, and has a poor prognosis. Other than curative primary resection, no effective treatment options exist. We present a case of resected HCS with four repeat resections for solitary lymph node recurrence followed by chemoradiotherapy with doxorubicin and ifosfamide. A 67-year-old Japanese man was admitted to our hospital for evaluation of an asymptomatic hepatic tumor. The patient underwent right hepatectomy with a presumptive preoperative diagnosis of atypical hepatocellular carcinoma. Based on histopathological and immunohistochemical findings, the tumor was diagnosed as HCS containing osteosarcoma and chondrosarcoma components. After the initial surgery, the patient underwent four additional resections for solitary lymph node HCS recurrence, and then underwent chemoradiotherapy with doxorubicin and ifosfamide for an unresectable lymph node recurrence. Chemotherapy was stopped after two cycles because of severe adverse events, although chemoradiotherapy markedly reduced the size of the lymph node recurrence and provided a progression-free survival of 12 months. Thirty-seven months after the initial surgery, the patient died of cardiac invasion of multiple mediastinal lymph node metastases. The clinical course outlined in this case report suggests that chemoradiotherapy with doxorubicin and ifosfamide for metastatic HCS may prolong survival in patients with unresectable lesions. Nagoya University 2018-08 /pmc/articles/PMC6125652/ /pubmed/30214092 http://dx.doi.org/10.18999/nagjms.80.3.423 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kurita, Daisuke
Mokuno, Yasuji
Matsubara, Hideo
Kaneko, Hirokazu
Shamoto, Mikihiro
Satou, Akira
Iyomasa, Shinsuke
Primary hepatic carcinosarcoma with multimodal treatment
title Primary hepatic carcinosarcoma with multimodal treatment
title_full Primary hepatic carcinosarcoma with multimodal treatment
title_fullStr Primary hepatic carcinosarcoma with multimodal treatment
title_full_unstemmed Primary hepatic carcinosarcoma with multimodal treatment
title_short Primary hepatic carcinosarcoma with multimodal treatment
title_sort primary hepatic carcinosarcoma with multimodal treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125652/
https://www.ncbi.nlm.nih.gov/pubmed/30214092
http://dx.doi.org/10.18999/nagjms.80.3.423
work_keys_str_mv AT kuritadaisuke primaryhepaticcarcinosarcomawithmultimodaltreatment
AT mokunoyasuji primaryhepaticcarcinosarcomawithmultimodaltreatment
AT matsubarahideo primaryhepaticcarcinosarcomawithmultimodaltreatment
AT kanekohirokazu primaryhepaticcarcinosarcomawithmultimodaltreatment
AT shamotomikihiro primaryhepaticcarcinosarcomawithmultimodaltreatment
AT satouakira primaryhepaticcarcinosarcomawithmultimodaltreatment
AT iyomasashinsuke primaryhepaticcarcinosarcomawithmultimodaltreatment